TP53 and neoplasm: Simultaneously, β-hydroxybutyrate can induce the β-hydroxybutyrylation of p53, leading to an obvious decrease in the acetylation levels and activities of p53, which ultimately promote the growth of tumor cells (Liu et al., 2019).